Neuron Regeneration Weekly Digest: MS Immune Communication, Parkinson’s Motor Protection, and GPR84 Targeting After Stroke

by J Carter | Oct 24, 2026 | Uncategorized

Researchers studying multiple sclerosis, Parkinson’s disease, and ischemic stroke are uncovering distinct biological processes that may be targeted to protect the nervous system. In newly diagnosed MS, protein changes in monocytes and B cells pointed to disrupted...

Neuron Regeneration Weekly Digest: Parkinson’s Neuroprotection, MS Inflammation, and Microglial Repair in Vascular Dementia

by J Carter | Sep 19, 2026 | Uncategorized

Protecting neurons and repairing damaged brain tissue are central goals in treating neurodegenerative diseases. In a rat model of Parkinson’s disease, a fatty acid-derived compound called 10-NO₂-OA reduced dopamine-neuron damage and improved motor function by...

Neuron Regeneration Weekly Digest: New Neuroprotective Strategies for Tau Aggregation, Brain Injury, and Parkinson’s Disease

by J Carter | Aug 22, 2026 | Uncategorized

The brain can be harmed by abnormal protein buildup, traumatic injury, and progressive neuron loss. Three recent studies explore different conditions but share a common theme: protecting the brain may depend on strengthening natural defenses and limiting damaging...

Neuron Regeneration Weekly Digest: Microglial Inflammation, Brain Injury Immune Remodeling, and LRRK2-Driven Synaptic Function

by J Carter | Aug 15, 2026 | Uncategorized

The brain’s response to disease and injury depends on a complex interaction between inflammation, immune activity, and the health of neuronal connections. In multiple sclerosis, researchers identified the FLAP/LTB4 pathway in microglia as a potential target for...

Neuron Regeneration Weekly Digest: Parkinson’s Vaccines, Spinal Cord Lipid Metabolism, and ALS Cholesterol Genetics

by J Carter | Aug 8, 2026 | Uncategorized

These studies show how different neurological conditions may share a common opportunity: targeting biological processes that drive nerve damage. In Parkinson’s disease, a vaccine trained the immune system to recognize harmful α-synuclein aggregates and delayed...